M&T Bank’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5
Closed -$11K 1612
2021
Q4
$11K Hold
5
﹤0.01% 1558
2021
Q3
$62K Hold
5
﹤0.01% 1501
2021
Q2
$10K Buy
+5
New +$894 ﹤0.01% 1564
2021
Q1
Sell
-5
Closed -$1K 1657
2020
Q4
$1K Buy
+5
New +$506 ﹤0.01% 1691

Other funds holding MRNA

M&T Bank's MRNA Position: Q1 2026 in Review

M&T Bank increased its Moderna (MRNA) stake by 11% in Q1 2026, buying an estimated $124K and bringing the position to 27,612 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #713.

M&T Bank first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $5.69M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • M&T Bank held 27,612 shares of Moderna worth $1.4M as of Q1 2026.
  • M&T Bank bought 2,654 Moderna shares in Q1 2026, an estimated $124K.
  • Moderna made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #713 holding.
  • M&T Bank first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • M&T Bank's Moderna position peaked at $5.69M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.